Showing results (91-100 of 103) with videos related to
Sort By:
Pageof 11
Bioorganic Chemistry|January 12, 2019
Identification of 1,2,4-triazoles as new thymidine phosphorylase inhibitors: Future anti-tumor drugsSohail Anjum Shahzad, Muhammad Yar, Zulfiqar Ali Khan, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|January 20, 2021
Pyridinium-2-carbaldoximes with quinolinium carboxamide moiety are simultaneous reactivators of acetylcholinesterase and butyrylcholinesterase inhibited by nerve agent surrogatesHyun Myung Lee, Rudolf Andrys, Jakub Jonczyk, et al.ACS Chemical Neuroscience|January 19, 2018
Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer's AgentsDawid Panek, Anna Więckowska, Jakub Jończyk, et al.European Journal of Medicinal Chemistry|May 20, 2021
Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activityPaula Zaręba, Kinga Sałat, Georg C Höfner, et al.Chemical Biology & Drug Design|November 14, 2018
Characteristics of metabolic stability and the cell permeability of 2-pyrimidinyl-piperazinyl-alkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione with antidepressant- and anxiolytic-like activitiesAgnieszka Zagórska, Anna Partyka, Adam Bucki, et al.Bioorganic Chemistry|July 5, 2019
Search for multifunctional agents against Alzheimer's disease among non-imidazole histamine H3 receptor ligands. In vitro and in vivo pharmacological evaluation and computational studies of piperazine derivativesJakub Jończyk, Krzysztof Lodarski, Marek Staszewski, et al.International Journal of Molecular Sciences|August 12, 2022
Discovery of the First Highly Selective Antagonist of the GluK3 Kainate Receptor SubtypePaulina Chałupnik, Alina Vialko, Darryl S Pickering, et al.Bioorganic Chemistry|July 4, 2021
Cyanobiphenyls: Novel H3 receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer's diseaseJustyna Godyń, Paula Zaręba, Dorota Łażewska, et al.European Journal of Medicinal Chemistry|October 14, 2023
Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's diseasePaula Zaręba, Kamil Łątka, Gabriela Mazur, et al.European Journal of Medicinal Chemistry|September 4, 2020
Rational design of new multitarget histamine H3 receptor ligands as potential candidates for treatment of Alzheimer's diseaseDorota Łażewska, Marek Bajda, Maria Kaleta, et al.Pageof 11